Edmond DE Rothschild Holding S.A. Cuts Stock Holdings in Doximity, Inc. (NASDAQ:DOCS)

Edmond DE Rothschild Holding S.A. cut its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 45.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 555,165 shares of the company’s stock after selling 467,004 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in Doximity were worth $29,640,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Global Retirement Partners LLC grew its position in Doximity by 468.1% during the fourth quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after acquiring an additional 440 shares during the period. UMB Bank n.a. raised its holdings in Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after buying an additional 235 shares during the period. Larson Financial Group LLC lifted its position in Doximity by 49.4% during the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after buying an additional 250 shares in the last quarter. Optimum Investment Advisors purchased a new stake in Doximity during the fourth quarter worth approximately $43,000. Finally, Morse Asset Management Inc purchased a new stake in Doximity during the 3rd quarter worth $46,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Price Performance

Shares of DOCS opened at $58.40 on Monday. The stock has a market capitalization of $10.90 billion, a PE ratio of 58.40, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34. The business’s fifty day moving average price is $65.48 and its 200 day moving average price is $54.55. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Wall Street Analysts Forecast Growth

DOCS has been the topic of several research reports. Mizuho raised their price objective on Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a research report on Monday, February 10th. Leerink Partners raised shares of Doximity from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $60.00 to $90.00 in a research report on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a “neutral” rating to an “overweight” rating and lifted their price objective for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Wells Fargo & Company restated an “equal weight” rating on shares of Doximity in a research note on Friday, February 7th. Finally, Raymond James reaffirmed an “outperform” rating and set a $83.00 price target (up previously from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have given a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat, Doximity has a consensus rating of “Moderate Buy” and a consensus price target of $64.22.

Insider Transactions at Doximity

In related news, Director Timothy S. Cabral sold 20,000 shares of the stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the sale, the director now owns 6,360 shares in the company, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 37.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.